BioSpace News Archive

Deals

LivaNova Reports First Quarter 2019 Results

LivaNova PLC, a market-leading medical technology and innovation company, reported results for the quarter ended March 31, 2019.

May 1, 2019
·
13 min read
Deals

Caris Life Sciences Acquires Pharmatech

Purchase of leading Just-In-Time clinical trials recruitment service will benefit patients, physicians and drug developers by connecting cancer patients to the right trials faster

May 1, 2019
·
4 min read
Deals

Allergan Announces Results from the 2019 Annual General Meeting of Shareholders

Shareholders Approved All Allergan Proposals and Voted AGAINST Shareholder Proposal Calling for Immediate Separation of Chairman and CEO Role

May 1, 2019
·
4 min read
Business

IDEXX Laboratories Announces First Quarter Results - May 1, 2019

Reports revenue growth of 7% on a reported basis and 10% on an organic basis, driven by CAG Diagnostics recurring revenue growth of 9% reported and 12% organic

May 1, 2019
·
18 min read
Canada’s Newly Certified Medical Specialists Struggle to Find Work

A study based on a multi-year survey of 6,200 specialists released by the Royal College of Physicians and Surgeons of Canada revealed the highest percentage of reported employment challenges since the launch of the Royal College Employment Survey in 2011.

May 1, 2019
·
3 min read
Deals

Sensient Technologies Corporation Reports Results for the Quarter Ended March 31, 2019

Sensient Technologies Corporation reported earnings per share of 78 cents in the first quarter of 2019 compared to 89 cents in last year’s first quarter.

May 1, 2019
·
14 min read
Drug Development

Precision Protein® -- The Next Generation of Whey Protein Supplementation from Hi-Tech Pharmaceuticals Enters Phase 3 Launch!

Precision Protein® marks the beginning of a new era in whey-protein formulation and supplementation.

May 1, 2019
·
7 min read
BioCapital

MaxCyte Presents at 22nd Annual ASGCT Meeting on Manufacturing Process for First CARMA™ Drug Candidate, Including One-Day Cell Processing

CARMA drug candidates can be manufactured via streamlined, single-day process, providing a much needed faster turnaround of autologous cell therapy to patients

May 1, 2019
·
3 min read
Business

Variant Pharmaceuticals Has a New Name - ZyVersa Therapeutics, Inc.

Reflects the versatility required to be on the forefront of innovation to meet unmet medical needs

May 1, 2019
·
1 min read
Genetown

AVEO Oncology to Participate in the 5th Annual SunTrust Robinson Humphrey Life Sciences Summit

AVEO Oncology announced that members of the management team will participate in the 5th Annual SunTrust Robinson Humphrey Life Sciences Summit on Wednesday, May 8, 2019.

May 1, 2019
·
3 min read